{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:55:23Z","timestamp":1769284523599,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.vaccine.2016.02.038","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T11:27:13Z","timestamp":1456226833000},"page":"1665-1671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Immunisation with proteins expressed during chronic murine melioidosis provides enhanced protection against disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Olivia L.","family":"Champion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise J.","family":"Gourlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew E.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Lassaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Conejero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Perletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Hemsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joann","family":"Prior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Bancroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martino","family":"Bolognesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.","family":"Titball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.02.038_bib0170","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","article-title":"Melioidosis: epidemiology, pathophysiology and management","volume":"18","author":"Cheng","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0175","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4269\/ajtmh.2010.10-0038","article-title":"Increasing incidence of human melioidosis in Northeast Thailand","volume":"82","author":"Limmathurotsakul","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0001-706X(99)00060-1","article-title":"The epidemiology of melioidosis in Australia and Papua New Guinea","volume":"74","author":"Currie","year":"2000","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0185","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro1385","article-title":"Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei","volume":"4","author":"Wiersinga","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/24.3.295","article-title":"The antimicrobial susceptibility of Pseudomonas pseudomallei\u2014emergence of resistance in vitro and during treatment","volume":"24","author":"Dance","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0195","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(03)13374-0","article-title":"Melioidosis","volume":"361","author":"White","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0200","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijantimicag.2014.01.005","article-title":"Treatment and prophylaxis of melioidosis","volume":"43","author":"Dance","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0205","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1056\/NEJMra1204699","article-title":"Melioidosis","volume":"367","author":"Wiersinga","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/bmb\/ldr007","article-title":"Melioidosis: a clinical overview","volume":"99","author":"Limmathurotsakul","year":"2011","journal-title":"Br Med Bull"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0215","doi-asserted-by":"crossref","first-page":"e1488","DOI":"10.1371\/journal.pntd.0001488","article-title":"Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes","volume":"6","author":"Peacock","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0220","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fmicb.2011.00198","article-title":"Development of vaccines against Burkholderia pseudomallei","volume":"2","author":"Patel","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fcimb.2013.00010","article-title":"Development of Burkholderia mallei and pseudomallei vaccines","volume":"3","author":"Silva","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fcimb.2013.00005","article-title":"Burkholderia vaccines: are we moving forward?","volume":"3","author":"Choh","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0235","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0240","doi-asserted-by":"crossref","first-page":"53ra74","DOI":"10.1126\/scitranslmed.3001094","article-title":"A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis","volume":"2","author":"Bertholet","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0245","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J Clin Invest"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.02.038_bib0250","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2334-14-S1-S2","article-title":"Vaccine against tuberculosis: what's new?","volume":"14","author":"Montagnani","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0255","doi-asserted-by":"crossref","first-page":"e1003795","DOI":"10.1371\/journal.pgen.1003795","article-title":"The condition-dependent transcriptional landscape of Burkholderia pseudomallei","volume":"9","author":"Ooi","year":"2013","journal-title":"PLoS Genet"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.02.038_bib0260","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S0035-9203(08)70026-9","article-title":"Burkholderia pseudomallei: animal models of infection","volume":"102","author":"Titball","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0265","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/bioinformatics\/btq249","article-title":"PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes","volume":"26","author":"Yu","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0270","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/498983","article-title":"Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection","volume":"193","author":"Haque","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0275","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1186\/gb-2010-11-8-r89","article-title":"Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates","volume":"11","author":"Sim","year":"2010","journal-title":"Genome Biol"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0280","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2144\/99265bm05","article-title":"The pKNOCK series of broad-host-range mobilizable suicide vectors for gene knockout and targeted DNA insertion into the chromosome of gram-negative bacteria","volume":"26","author":"Alexeyev","year":"1999","journal-title":"Biotechniques"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0285","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1099\/0022-1317-51-12-1055","article-title":"Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins","volume":"51","author":"Jones","year":"2002","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0290","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1099\/0022-1317-51-7-539","article-title":"Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis","volume":"51","author":"Atkins","year":"2002","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0295","first-page":"108","article-title":"Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders","volume":"2","author":"Burtnick","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0300","doi-asserted-by":"crossref","first-page":"392170","DOI":"10.1155\/2014\/392170","article-title":"Protection against experimental melioidosis following immunisation with a lipopolysaccharide\u2013protein conjugate","volume":"2014","author":"Scott","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0305","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajpath.2011.03.031","article-title":"Low-dose exposure of C57BL\/6 mice to Burkholderia pseudomallei mimics chronic human melioidosis","volume":"179","author":"Conejero","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0310","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jmb.2004.02.027","article-title":"Crystal structure of IscA, an iron\u2013sulfur cluster assembly protein from Escherichia coli","volume":"338","author":"Cupp-Vickery","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0315","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/infdis\/jiq142","article-title":"Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis","volume":"203","author":"Suwannasaen","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0320","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.chembiol.2013.07.010","article-title":"Exploiting the Burkholderia pseudomallei acute phase antigen BPSL2765 for structure-based epitope discovery\/design in structural vaccinology","volume":"20","author":"Gourlay","year":"2013","journal-title":"Chem Biol"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0325","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1099\/jmm.0.45766-0","article-title":"Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis","volume":"53","author":"Nelson","year":"2004","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.038_bib0330","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1128\/IAI.00404-07","article-title":"Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis","volume":"75","author":"Harland","year":"2007","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T05:16:19Z","timestamp":1572326179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16002012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":33,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0264410X16002012"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunisation with proteins expressed during chronic murine melioidosis provides enhanced protection against disease","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}